ArticleLeukemia2024

Loss of hematopoietic progenitors heterogeneity is an adverse prognostic factor in lower-risk myelodysplastic neoplasms.

Charles Dussiau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.